HOME >> MEDICINE >> NEWS
Study shows Erbitux may fight colorectal cancer after other therapies fail

ORLANDO, Fla.-Cetuximab, also known as Erbitux, can battle cancer and prolong life in many patients with advanced colorectal cancer who have exhausted all other treatments, according to research presented at the 2005 Annual Meeting of the American Society of Clinical Oncology.

"Even in people who have gone through six or more previous courses of chemotherapy, cetuximab, may fight the growth of cancer, giving patients additional months of life," says study presenter Heinz-Josef Lenz, M.D., associate professor of medicine at the Keck School of Medicine of the University of Southern California and USC/Norris Comprehensive Cancer Center.

Lenz and researchers at five other university medical centers in the United States and Europe offered the phase II trial of cetuximab to patients with metastatic colorectal cancer who had already tried and failed treatment with fluoropyrimidine drugs (such as 5-FU) and the drugs irinotecan and oxaliplatin. Some patients had undergone as many as nine prior courses of chemotherapy.

In all, 346 patients participated, and 12 percent of patients saw their tumors shrink, at least temporarily, in response to the drug. The typical patient survived 6.6 months after treatment.

Colorectal cancer is the third most common cancer in the U.S., with nearly 145,300 new cases and nearly 56,300 deaths from the disease expected this year, according to the American Cancer Society. As Lenz explains, the death rate for colorectal cancer has been declining for 15 years because better detection methods are turning up tumors in their early stages, when they can most easily be treated.

The five-year relative survival rate for people whose colorectal cancer is treated in an early stage, before it has spread, is greater than 90 percent. But only 39 percent of colorectal cancers are found at that early stage.

"Unfortunately, treatment for colorectal cancer is much more challenging when the cancer has advanced," says
'"/>

Contact: Jon Weiner
jon.weiner@usc.edu
323-442-2830
University of Southern California
17-May-2005


Page: 1 2

Related medicine news :

1. Study, meta-analysis examine factors associated with death from heatstroke
2. Study says COPD testing is not measuring up
3. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
4. Study reveals gaps in vaccine financing for underinsured children
5. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
6. Study shows radiofrequency ablation highly effective in treating kidney tumors
7. Study says normal but out-of-control enzyme may be culprit that signals some cells to become cancer
8. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
9. Study outlines how stroke, head injury can increase risk of Alzheimers disease
10. Study identifies new regulator of fat metabolism
11. Study shows Diachrome improves blood sugar control in people with type 2 diabetes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... 12, 2017 , ... Vohra Chief Medical Officer Dr. Shark ... skilled nursing facility medical directors and other clinicians at various events in October. ... "At many of these conferences we get to educate other physicians, facility nurses, ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
Breaking Medicine Technology:
Cached News: